Glucagon-like peptide-1 receptor and sarcoglycan delta genetic variants can affect cardiovascular risk in chronic kidney disease patients under hemodialysis
Academic Article
Publication Date:
2020
Short description:
Glucagon-like peptide-1 receptor and sarcoglycan delta genetic variants can affect cardiovascular risk in chronic kidney disease patients under hemodialysis / Terranegra, A., Arcidiacono, T., Macrina, L., Brasacchio, C., Pivari, F., Mingione, A., Tomei, S., Mezzavilla, M., Silcock, L., Cozzolino, M., Palmieri, N., Conte, F., Sirtori, M., Rubinacci, A., Soldati, L., Vezzoli, G.. - In: CLINICAL KIDNEY JOURNAL. - ISSN 2048-8505. - 13:4(2020), pp. 666-673-673. [10.1093/ckj/sfz182]
abstract:
Chronic kidney disease (CKD) patients under hemodialysis show a higher risk of cardiovascular (CV) mortality and morbidity than the general population. This study aims to identify genetic markers that could explain the increased CV risk in hemodialysis.
Iris type:
1.1 Articolo in rivista
Keywords:
cardiovascular disease; chronic kidney disease; gene polymorphism; genetics; hemodialysis
List of contributors:
Terranegra, Annalisa; Arcidiacono, Teresa; Macrina, Lorenza; Brasacchio, Caterina; Pivari, Francesca; Mingione, Alessandra; Tomei, Sara; Mezzavilla, Massimo; Silcock, Lee; Cozzolino, Mario; Palmieri, Nicola; Conte, Ferruccio; Sirtori, Marcella; Rubinacci, Alessandro; Soldati, Laura; Vezzoli, Giuseppe
Published in: